While previous research indicated an increase in ADAMTS1 expression in kidney cancer [19], there is limited information regarding its potential clinical predictive significance in RCC, particularly with regards to the influence of ADAMTS1 on RCC’s resistance to anoikis and the underlying mechanisms of this phenomenon. This evidence concerns the gene ADAMTS1 and renal cell carcinoma.